609 related articles for article (PubMed ID: 35955885)
1. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
[TBL] [Abstract][Full Text] [Related]
2. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different.
Malnick SDH; Alin P; Somin M; Neuman MG
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555867
[TBL] [Abstract][Full Text] [Related]
3. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
4. Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease.
Dukić M; Radonjić T; Jovanović I; Zdravković M; Todorović Z; Kraišnik N; Aranđelović B; Mandić O; Popadić V; Nikolić N; Klašnja S; Manojlović A; Divac A; Gačić J; Brajković M; Oprić S; Popović M; Branković M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835145
[TBL] [Abstract][Full Text] [Related]
5. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
Boye A; Zou YH; Yang Y
World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
[TBL] [Abstract][Full Text] [Related]
6. Protective Mechanism of Edible Food Plants against Alcoholic Liver Disease with Special Mention to Polyphenolic Compounds.
Zhao L; Mehmood A; Yuan D; Usman M; Murtaza MA; Yaqoob S; Wang C
Nutrients; 2021 May; 13(5):. PubMed ID: 34064981
[TBL] [Abstract][Full Text] [Related]
7. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
8. Alcoholic liver disease.
Seitz HK; Bataller R; Cortez-Pinto H; Gao B; Gual A; Lackner C; Mathurin P; Mueller S; Szabo G; Tsukamoto H
Nat Rev Dis Primers; 2018 Aug; 4(1):16. PubMed ID: 30115921
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
10. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
Ranjbarian T; Schnabl B
Semin Liver Dis; 2023 Aug; 43(3):311-322. PubMed ID: 37527781
[TBL] [Abstract][Full Text] [Related]
12. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
Way GW; Jackson KG; Muscu SR; Zhou H
Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
[TBL] [Abstract][Full Text] [Related]
13. Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research.
Neuman MG; Seitz HK; French SW; Malnick S; Tsukamoto H; Cohen LB; Hoffman P; Tabakoff B; Fasullo M; Nagy LE; Tuma PL; Schnabl B; Mueller S; Groebner JL; Barbara FA; Yue J; Nikko A; Alejandro M; Brittany T; Edward V; Harrall K; Saba L; Mihai O
Biomedicines; 2020 Mar; 8(3):. PubMed ID: 32197424
[TBL] [Abstract][Full Text] [Related]
14. The metabolomic window into hepatobiliary disease.
Beyoğlu D; Idle JR
J Hepatol; 2013 Oct; 59(4):842-58. PubMed ID: 23714158
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
[TBL] [Abstract][Full Text] [Related]
16. Alcohol and the mechanisms of liver disease.
Chen M; Zhong W; Xu W
J Gastroenterol Hepatol; 2023 Aug; 38(8):1233-1240. PubMed ID: 37423758
[TBL] [Abstract][Full Text] [Related]
17. Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments.
Argemi J; Ventura-Cots M; Rachakonda V; Bataller R
Rev Esp Enferm Dig; 2020 Nov; 112(11):869-878. PubMed ID: 33054302
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.
Jung JH; Kim SE; Suk KT; Kim DJ
Front Med (Lausanne); 2022; 9():913842. PubMed ID: 35935787
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease.
Yang YM; Cho YE; Hwang S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054960
[TBL] [Abstract][Full Text] [Related]
20. Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation.
Novi S; Vestuto V; Campiglia P; Tecce N; Bertamino A; Tecce MF
Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
